Conflict of Interest Policy

Conflict of Interest Policy: Scientific Advisory Council on Longevity

‍

Effective October 1, 2026

Members of the Global Healthcare Accreditation (GHA) Scientific Advisory Council on Longevity must disclose any financial or professional interest that could influence their advice on the Healthy Longevity Medicine Standard. Members with a conflict do not vote on the affected decisions. GHA publishes a summary of each member’s disclosures on this page.

Purpose

The Healthy Longevity Medicine Standard is used by clinics, employers, insurers and patients to decide which longevity care providers to trust. That trust depends on the standard being written independently of the companies and products it evaluates. This policy explains how GHA identifies and manages conflicts of interest so that the Council’s advice reflects the evidence and nothing else.

Who this policy applies to

This policy applies to every member of the Scientific Advisory Council on Longevity. It also applies to invited experts who give the Council evidence or advice on a specific topic.

What members must disclose

Members disclose any interest held in the past 36 months by themselves, their spouse or partner, or their dependent children. Interests include:

  • Employment, board seats or leadership roles with a company that sells longevity products, tests or services
  • Equity, stock options or ownership in such a company, other than holdings in broad mutual funds
  • Patents, royalties or licensing income, including income received through a university
  • Consulting, advisory or speaking fees
  • Research funding from a company, where the research relates to longevity products or services
  • Founding or advising a clinic, laboratory or test provider
  • Leadership roles in professional societies or advocacy organizations whose positions relate to the standard

Having expertise, publications or a public scientific view on a topic is not a conflict of interest. A financial interest in the outcome is.

When members disclose

  • Before appointment, on the GHA Declaration of Interests
  • Every year after that
  • Within 30 days of any change
  • At the start of any review item where an interest may apply

How conflicts are managed

GHA reviews every disclosure and assigns one of three outcomes for each review item:

  1. No conflict. The member takes full part.
  2. Conflict managed by disclosure and recusal. The member may present evidence or answer questions when the Council asks. The member does not take part in deliberation or voting on that item and does not count toward quorum for it.
  3. Conflict too broad to manage. Where an interest affects most of the Council’s work, the person may serve as an invited expert rather than a member.

For example, a member who holds a patent on, or receives income from, a biological age test may share scientific evidence on biological age testing. That member does not vote on whether such tests may be used clinically, or on any requirement that names a specific test.

Recording and transparency

  • Every recusal is recorded in the meeting record.
  • GHA publishes a summary of each member’s declared interests on this page and updates it every year.
  • The Council is advisory. Its recommendations go to the GHA Standards Committee before any change to the standard is adopted, and accreditation decisions remain with GHA.

Use of Council membership

Members may describe their role on the Council. Members may not use their membership, or GHA’s name, to market or endorse any product, test, clinic or service. Members may not accept payment from an accredited or applicant organization in connection with that organization’s accreditation.

If the policy is not followed

A member who fails to disclose an interest, or takes part in a decision despite a conflict, may be asked to step down. GHA will review any decision affected by an undisclosed conflict and may reopen it.

Frequently asked questions

Does a commercial interest disqualify someone from the Council?

‍No. Many leading scientists in longevity medicine have ties to companies. The policy requires these interests to be disclosed and managed, so that the Council can draw on the best expertise while keeping its decisions independent.

Can a scientist who developed a test advise on that test?

‍Yes, as a source of evidence. They do not vote on decisions that affect the test’s used

Where can I see members’ disclosures?

‍A summary for each member appears on this page once members are confirmed.

‍